MedPath

The efficacy of fibroblast growth factor for the treatment of chronic vocal fold scarring

Not Applicable
Completed
Conditions
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Registration Number
KCT0001855
Lead Sponsor
Soon Chun Hyang University Hospital Bucheon
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
17
Inclusion Criteria

Based on the results of a stroboscopic examination, history of chronic vocal fold scarring of over 1 year’s duration

Exclusion Criteria

Patients with a history of other vocal fold diseases, such as vocal fold atrophy, vocal fold mucosal lesion, granuloma, or sulcus vocalis, or a history of malignant tumors of the vocal fold were excluded.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Voice evaluation (jitter and shimmer,harmonics-to-noise ratio,maximum phonation time,voice range profile, GRBAS(Grade, Roughness, Breathiness, Asthenia, Strain) scale, Voice Handicap Index ,stroboscopy)
Secondary Outcome Measures
NameTimeMethod
Safety
© Copyright 2025. All Rights Reserved by MedPath